106 related articles for article (PubMed ID: 10329371)
1. Binding of gelsolin, a secretory protein, to amyloid beta-protein.
Chauhan VP; Ray I; Chauhan A; Wisniewski HM
Biochem Biophys Res Commun; 1999 May; 258(2):241-6. PubMed ID: 10329371
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic gelsolin in pheochromocytoma-12 cells forms a complex with amyloid beta-protein.
Ji L; Chauhan A; Chauhan V
Neuroreport; 2008 Mar; 19(4):463-6. PubMed ID: 18287947
[TBL] [Abstract][Full Text] [Related]
3. Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer's disease.
Chauhan V; Ji L; Chauhan A
Biogerontology; 2008 Dec; 9(6):381-9. PubMed ID: 18704746
[TBL] [Abstract][Full Text] [Related]
4. Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid.
Yamauchi K; Tozuka M; Nakabayashi T; Sugano M; Hidaka H; Kondo Y; Katsuyama T
J Neurosci Res; 1999 Oct; 58(2):301-7. PubMed ID: 10502286
[TBL] [Abstract][Full Text] [Related]
5. Binding of trypsin to fibrillar amyloid beta-protein.
Chander H; Chauhan A; Wegiel J; Malik M; Sheikh A; Chauhan V
Brain Res; 2006 Apr; 1082(1):173-81. PubMed ID: 16510132
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.
Wisniewski T; Golabek A; Matsubara E; Ghiso J; Frangione B
Biochem Biophys Res Commun; 1993 Apr; 192(2):359-65. PubMed ID: 8484748
[TBL] [Abstract][Full Text] [Related]
7. Secondary structure conversions of Alzheimer's Abeta(1-40) peptide induced by membrane-mimicking detergents.
Wahlström A; Hugonin L; Perálvarez-Marín A; Jarvet J; Gräslund A
FEBS J; 2008 Oct; 275(20):5117-28. PubMed ID: 18786140
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.
Barten DM; Guss VL; Corsa JA; Loo A; Hansel SB; Zheng M; Munoz B; Srinivasan K; Wang B; Robertson BJ; Polson CT; Wang J; Roberts SB; Hendrick JP; Anderson JJ; Loy JK; Denton R; Verdoorn TA; Smith DW; Felsenstein KM
J Pharmacol Exp Ther; 2005 Feb; 312(2):635-43. PubMed ID: 15452193
[TBL] [Abstract][Full Text] [Related]
10. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.
Fagan AM; Mintun MA; Mach RH; Lee SY; Dence CS; Shah AR; LaRossa GN; Spinner ML; Klunk WE; Mathis CA; DeKosky ST; Morris JC; Holtzman DM
Ann Neurol; 2006 Mar; 59(3):512-9. PubMed ID: 16372280
[TBL] [Abstract][Full Text] [Related]
11. [Genetic factors for cerebral amyloid angiopathy].
Hamaguchi T; Yamada M
Brain Nerve; 2008 Nov; 60(11):1275-83. PubMed ID: 19069161
[TBL] [Abstract][Full Text] [Related]
12. Contribution of cysteine 158, the glycosylation site threonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40).
Aleshkov SB; Li X; Lavrentiadou SN; Zannis VI
Biochemistry; 1999 Jul; 38(28):8918-25. PubMed ID: 10413465
[TBL] [Abstract][Full Text] [Related]
13. Relationship between proteolytically cleaved gelsolin and levels of amyloid-β protein in the brains of Down syndrome subjects.
Ji L; Chauhan V; Mehta P; Wegiel J; Mehta S; Chauhan A
J Alzheimers Dis; 2010; 22(2):609-17. PubMed ID: 20847428
[TBL] [Abstract][Full Text] [Related]
14. Specific interaction of VEGF165 with beta-amyloid, and its protective effect on beta-amyloid-induced neurotoxicity.
Yang SP; Kwon BO; Gho YS; Chae CB
J Neurochem; 2005 Apr; 93(1):118-27. PubMed ID: 15773911
[TBL] [Abstract][Full Text] [Related]
15. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation.
Sastre M; Calero M; Pawlik M; Mathews PM; Kumar A; Danilov V; Schmidt SD; Nixon RA; Frangione B; Levy E
Neurobiol Aging; 2004 Sep; 25(8):1033-43. PubMed ID: 15212828
[TBL] [Abstract][Full Text] [Related]
16. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides.
Bibl M; Esselmann H; Otto M; Lewczuk P; Cepek L; Rüther E; Kornhuber J; Wiltfang J
Electrophoresis; 2004 Sep; 25(17):2912-8. PubMed ID: 15349929
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi.
Park HJ; Seong YM; Choi JY; Kang S; Rhim H
Neurosci Lett; 2004 Feb; 357(1):63-7. PubMed ID: 15036614
[TBL] [Abstract][Full Text] [Related]
19. Zinc binding to Alzheimer's Abeta(1-16) peptide results in stable soluble complex.
Kozin SA; Zirah S; Rebuffat S; Hoa GH; Debey P
Biochem Biophys Res Commun; 2001 Jul; 285(4):959-64. PubMed ID: 11467845
[TBL] [Abstract][Full Text] [Related]
20. Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E.
Golabek AA; Kida E; Walus M; Perez C; Wisniewski T; Soto C
Biophys J; 2000 Aug; 79(2):1008-15. PubMed ID: 10920030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
